JP2017514816A5 - - Google Patents

Download PDF

Info

Publication number
JP2017514816A5
JP2017514816A5 JP2016564185A JP2016564185A JP2017514816A5 JP 2017514816 A5 JP2017514816 A5 JP 2017514816A5 JP 2016564185 A JP2016564185 A JP 2016564185A JP 2016564185 A JP2016564185 A JP 2016564185A JP 2017514816 A5 JP2017514816 A5 JP 2017514816A5
Authority
JP
Japan
Prior art keywords
day
acid
disclosed
conjugated
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016564185A
Other languages
English (en)
Japanese (ja)
Other versions
JP6730194B2 (ja
JP2017514816A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/060388 external-priority patent/WO2015169971A1/en
Publication of JP2017514816A publication Critical patent/JP2017514816A/ja
Publication of JP2017514816A5 publication Critical patent/JP2017514816A5/ja
Application granted granted Critical
Publication of JP6730194B2 publication Critical patent/JP6730194B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016564185A 2014-05-09 2015-05-11 アンドロゲン合成モジュレーター Active JP6730194B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461990800P 2014-05-09 2014-05-09
US61/990,800 2014-05-09
PCT/EP2015/060388 WO2015169971A1 (en) 2014-05-09 2015-05-11 Modulators of androgen synthesis

Publications (3)

Publication Number Publication Date
JP2017514816A JP2017514816A (ja) 2017-06-08
JP2017514816A5 true JP2017514816A5 (cg-RX-API-DMAC7.html) 2018-09-06
JP6730194B2 JP6730194B2 (ja) 2020-07-29

Family

ID=53269444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016564185A Active JP6730194B2 (ja) 2014-05-09 2015-05-11 アンドロゲン合成モジュレーター

Country Status (8)

Country Link
EP (1) EP3139923B1 (cg-RX-API-DMAC7.html)
JP (1) JP6730194B2 (cg-RX-API-DMAC7.html)
CN (1) CN106456644B (cg-RX-API-DMAC7.html)
AU (3) AU2015257594A1 (cg-RX-API-DMAC7.html)
CA (1) CA2950800C (cg-RX-API-DMAC7.html)
ES (1) ES2970762T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ726050A (cg-RX-API-DMAC7.html)
WO (1) WO2015169971A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2900270T3 (pl) 2012-09-26 2019-09-30 Tangent Reprofiling Limited Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym
US9375433B2 (en) 2012-09-26 2016-06-28 Tangent Reprofiling Limited Modulators of androgen synthesis
CA3049980A1 (en) 2017-01-23 2018-07-26 Regeneron Pharmaceuticals, Inc. Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
CA3059348A1 (en) 2017-04-11 2018-10-18 Regeneron Pharmaceuticals, Inc. Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family
AU2018348195B2 (en) 2017-10-11 2025-05-15 Regeneron Pharmaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
MY207352A (en) 2018-03-21 2025-02-21 Regeneron Pharma 17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof
MA56457A (fr) 2019-07-02 2022-05-11 Regeneron Pharma Modulateurs de hsd17b13 et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319950B1 (en) * 1997-02-18 2001-11-20 Michael C. Seidel Suppression of carcinoma using high purity conjugated linoleic acid (CLA)
CA2436536C (en) * 2000-12-23 2008-07-08 Creighton University Methods for inducing apoptosis and inhibiting proliferation in cancer cells
WO2004103262A2 (en) * 2003-05-22 2004-12-02 Yeda Research And Development Co. Ltd. Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells
WO2012129673A1 (en) * 2011-03-25 2012-10-04 Universite Laval INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
PL2900270T3 (pl) * 2012-09-26 2019-09-30 Tangent Reprofiling Limited Połączenie benzo(izo)oksazolopiperydyn ze sprzężonym kwasem linolowym
US9375433B2 (en) * 2012-09-26 2016-06-28 Tangent Reprofiling Limited Modulators of androgen synthesis

Similar Documents

Publication Publication Date Title
JP6734346B2 (ja) アンドロゲン合成モジュレーター
JP6730194B2 (ja) アンドロゲン合成モジュレーター
US10111877B2 (en) Modulators of androgen synthesis
KR20230084163A (ko) 항체-약물 접합체와 parp1 선택적 억제제의 조합
RU2009113615A (ru) Ингибитор киназы
JP5599773B2 (ja) リウマチ様関節炎又は急性骨髄性白血病の治療のためのシクロペンタ[g]キナゾリン誘導体
EA052190B1 (ru) Комбинация конъюгата антитела и лекарственного средства и селективного ингибитора parp1